The Guardian
الأكثر قراءة
المصدر: The Guardian
1 DayThe Guardian
المصدر: The Guardian
1 Dayجاهز للتشغيل
جاهز للتشغيل
The article discusses hair loss as a side effect of GLP-1 receptor agonists used for weight loss and type 2 diabetes. Around 20% of users report hair shedding, primarily within the first year, with two main types observed: temporary telogen effluvium caused by stress or rapid weight loss, and less common, permanent pattern baldness linked to genetics. Factors such as drug dosage, rapid calorie restriction, and nutritional deficiencies contribute to temporary hair loss, which often resolves over time. Experts suggest discussing concerns with a doctor and maintaining good nutrition, while noting that the health benefits of GLP-1 drugs generally outweigh potential cosmetic issues.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading